Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for imipramine hydrochloride (generic) from Oxford Pharmaceuticals, LLC. The action updates the labeling for this antide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine hydrochloride (Imipramine hydrochloride)

Snippet

SUPPL AP for IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)